(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

SUTRO

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

SUTRO

ST13

US500000098694731

Class

5, 40, 42

Filing

98694731

Registration

8357229

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

30

Latest update

07/21/2026

Trademark type

Word

Nice classes

5, 40, 42

Filing date

08/12/2024

Registration date

07/21/2026

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

07/21/2026

Last transaction

07/21/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

07/05/2017

First use in commerce

07/05/2017

Drawing code

4

Owner type

03

Owner location

South San Francisco, CA, US

Examiner

PATTERSON, MARY A

Law office

O70

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

Sutro Biopharma, Inc.

Representatives

Karen Won Mintz, Levin, Cohn, Ferris, Glovsky, and Popeo P.C.

Technical classification

Nice Classes

Class 5Class 40Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical and biological preparations for the immune system targeting immuno-oncology pathways; Pharmaceutical and biological preparations for use in oncology; Pharmaceuticals and biological preparations for prophylacticdiagnostictherapeutic use in treatingpreventingmanaging cancer; Therapeutic agents for medical useproteins and derivativesantibody-drug conjugatesimmunostimulatory antibody-drug conjugatesdual conjugatescytokinesbispecific antibodiesengineered antibodies for destroying tumor cells and stimulating immune response; Vaccines; Bacterial lysate preparations and bacterial extract preparationsfor use in the cell free production of therapeutic proteins and peptides for medical use

Class 40

Custom manufacturing of pharmaceuticals and therapeutic agents for medical use; Custom manufacturing of bacterial lysate preparations and bacterial extract preparations.

Class 42

Research and development in the fields of pharmaceuticalsbiologicschemistryprotein engineeringproteins and derivativesantibody-drug conjugatesimmunostimulatory antibody-drug conjugatesdual conjugatescytokinesbispecific antibodiesengineered antibodiesoncologyimmunology; Providing medical scientific research information in the fields of pharmaceuticalsbiologicschemistryprotein engineeringproteins and derivativesantibody-drug conjugatesimmunostimulatory anti-drug conjugatescytokinesbispecific antibodiesengineered antibodiesoncologyimmunology; Drug discoverycustom designdevelopment services featuring therapeutic agents for the treatment and prevention of diseases.

Publications

History of USPTO decisions and trademark events.

30 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

07/21/2026

R.PR

REGISTERED-PRINCIPAL REGISTER

07/21/2026

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

06/30/2026

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

06/30/2026

SUPC

STATEMENT OF USE PROCESSING COMPLETE

06/09/2026

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

06/09/2026

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

02/25/2026

IUAF

USE AMENDMENT FILED

02/24/2026

EISU

TEAS STATEMENT OF USE RECEIVED

02/24/2026

EX2G

SOU EXTENSION 2 GRANTED

02/24/2026

EXT2

SOU EXTENSION 2 FILED

02/24/2026

EEXT

SOU TEAS EXTENSION RECEIVED

02/24/2026

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

01/17/2026

EX1G

SOU EXTENSION 1 GRANTED

01/16/2026

EXT1

SOU EXTENSION 1 FILED

01/16/2026

EEXT

SOU TEAS EXTENSION RECEIVED

01/16/2026

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

07/22/2025

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

05/27/2025

PUBO

PUBLISHED FOR OPPOSITION

05/27/2025

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

05/21/2025

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

04/25/2025

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

04/22/2025

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

04/22/2025

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

04/22/2025

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

02/20/2025

GNRT

NON-FINAL ACTION E-MAILED

02/20/2025

CNRT

NON-FINAL ACTION WRITTEN

02/20/2025

DOCK

ASSIGNED TO EXAMINER

02/19/2025

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

01/16/2025

NWAP

NEW APPLICATION ENTERED

08/12/2024

Continuous trademark protection

Get notified about every new filing that threatens SUTRO or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.